McKesson, AMA Developing Reference Product for MDx | GenomeWeb

NEW YORK (GenomeWeb News) – The American Medical Association and McKesson announced a licensing deal today to create a reference product for identifying and tracking molecular diagnostic tests.

The deal calls for McKesson Z-Code Identifiers to be grouped and indexed with corresponding molecular pathology codes in the AMA's Current Procedural Terminology code set. With the resulting reference product, "the healthcare industry can better understand the growth in this area to support advanced diagnostics innovation," AMA and McKesson said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.